Remdesivir for COVID-19: challenges of underpowered studies

被引:62
|
作者
Norrie, John David [1 ]
机构
[1] Usher Inst, Edinburgh Clin Trials Unit, Edinburgh EH16 4UX, Midlothian, Scotland
来源
LANCET | 2020年 / 395卷 / 10236期
关键词
D O I
10.1016/S0140-6736(20)31023-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1525 / 1527
页数:4
相关论文
共 50 条
  • [1] Remdesivir and COVID-19
    Francesco Ferrara
    Raffaele La Porta
    Vilma D’Aiuto
    Antonio Vitiello
    Irish Journal of Medical Science (1971 -), 2021, 190 : 1237 - 1238
  • [2] Remdesivir and COVID-19
    Wang, Lei-Yun
    Cui, Jia-Jia
    Ouyang, Qian-Ying
    Zhan, Yan
    Guo, Cheng-Xian
    Yin, Ji-Ye
    LANCET, 2020, 396 (10256): : 953 - 954
  • [3] Remdesivir in covid-19
    Ferner, Robin E.
    Aronson, Jeffrey K.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [4] Remdesivir and COVID-19
    Ferrara, Francesco
    La Porta, Raffaele
    D'Aiuto, Vilma
    Vitiello, Antonio
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1237 - 1238
  • [5] Considerations and Challenges in the Remdesivir COVID-19 Pediatric Development Program
    Chan-Tack, Kirk
    Sampson, Mario
    Earp, Justin
    Arya, Vikram
    Yao, Lynne
    Alexander, John
    Hausman, Ethan
    Belew, Yodit
    Birnkrant, Debra
    Struble, Kimberly
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (02): : 259 - 265
  • [6] Remdesivir for the treatment of Covid-19: the value of biochemical studies
    Gotte, Matthias
    CURRENT OPINION IN VIROLOGY, 2021, 49 : 81 - 85
  • [7] Remdesivir for patients with COVID-19
    Wu, Peter E.
    Morris, Andrew M.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (04) : E125 - E125
  • [9] Remdesivir (Veklury) for COVID-19
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1612): : 186 - 188
  • [10] Remdesivir bei COVID-19
    Redaktion Facharztmagazine
    MMW - Fortschritte der Medizin, 2022, 164 (2) : 65 - 65